Cerus Corporation (CERS) Insider Trading Activity

NASDAQ$2.485+0.15 (6.41%)
Market Cap
$471.57M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
474 of 849
Rank in Industry
61 of 107

CERS Insider Trading Activity

CERS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$3,087,554
22
100

Related Transactions

BJERKHOLT ERICdirector
0
$0
1
$53,180
$-53,180
Jensen ChrystalChief Legal Officer
0
$0
4
$316,486
$-316,486
Benjamin Richard JChief Medical Officer
0
$0
4
$419,535
$-419,535
Green Kevin DennisChief Financial Officer
0
$0
4
$480,117
$-480,117
Jayaraman Vivek KChief Operating Officer
0
$0
6
$619,470
$-619,470
Greenman William MarinerPresident and CEO
0
$0
3
$1.2M
$-1.2M

About Cerus Corporation

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell …

Insider Activity of Cerus Corporation

Over the last 12 months, insiders at Cerus Corporation have bought $0 and sold $3.09M worth of Cerus Corporation stock.

On average, over the past 5 years, insiders at Cerus Corporation have bought $56,909 and sold $2.11M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $31,250 was made by Gregory Dean A. (director) on 2025‑08‑25.

List of Insider Buy and Sell Transactions, Cerus Corporation

2026-08-17SaleJensen ChrystalChief Legal Officer
30,000
0.015%
$2.98
$89,529
-16.84%
2026-07-16SaleJayaraman Vivek KChief Executive Officer
16,666
0.0082%
$3.16
$52,665
-21.18%
2026-06-30SaleGreenman William MarinerPresident and CEO
101,919
0.0513%
$2.94
$299,937
-11.64%
2026-06-30SaleJayaraman Vivek KChief Operating Officer
42,359
0.0213%
$2.94
$124,658
-11.64%
2026-06-30SaleGreen Kevin DennisChief Financial Officer
33,676
0.0169%
$2.94
$99,105
-11.64%
2026-06-30SaleJensen ChrystalChief Legal Officer
24,329
0.0122%
$2.94
$71,598
-11.64%
2026-06-09SaleBJERKHOLT ERICdirector
20,454
0.0103%
$2.60
$53,180
+0.39%
2026-05-29SaleJayaraman Vivek KChief Operating Officer
16,667
0.0082%
$3.00
$50,001
-14.47%
2026-05-01SaleJayaraman Vivek KChief Operating Officer
16,667
0.0092%
$3.00
$50,001
-4.41%
2026-03-12SaleGreenman William MarinerPresident and CEO
447,757
0.2271%
$1.66
$742,023
+50.00%
2026-03-12SaleJayaraman Vivek KChief Operating Officer
165,200
0.0838%
$1.66
$273,769
+50.00%
2026-03-12SaleGreen Kevin DennisChief Financial Officer
127,544
0.0647%
$1.66
$211,366
+50.00%
2026-03-12SaleBenjamin Richard JChief Medical Officer
101,740
0.0516%
$1.66
$168,604
+50.00%
2026-03-09SaleBenjamin Richard JChief Medical Officer
40,426
0.0205%
$1.88
$76,029
+31.87%
2026-03-06SaleGreenman William MarinerPresident and CEO
78,187
0.0423%
$2.01
$156,804
+31.61%
2026-03-06SaleJayaraman Vivek KChief Operating Officer
34,094
0.0184%
$2.01
$68,376
+31.61%
2026-03-06SaleGreen Kevin DennisChief Financial Officer
27,796
0.015%
$2.01
$55,745
+31.61%
2026-03-06SaleJensen ChrystalChief Legal Officer
30,845
0.0167%
$2.01
$61,860
+31.61%
2026-03-06SaleBenjamin Richard JChief Medical Officer
24,235
0.0131%
$2.01
$48,603
+31.61%
2026-03-05SaleGreen Kevin DennisChief Financial Officer
55,225
0.0291%
$2.06
$113,902
+24.26%
Total: 262
*Gray background shows transactions not older than one year

Insider Historical Profitability

20.53%
Greenman William MarinerPresident and CEO
5053036
2.5074%
$11.82M519
+31.07%
BJERKHOLT ERICdirector
261679
0.1298%
$612,328.8642
+13.43%
CORASH LAURENCE MChief Scientific Officer
2339740
1.161%
$5.47M378
+15.15%
CASSIN BJdirector
487921
0.2421%
$1.14M11
+54.29%
ANDERSON TIMOTHY Bdirector
200765
0.0996%
$469,790.1016
+47.63%
Witney Frankdirector
180059
0.0893%
$421,338.0620
+19.89%
GLASSELL CLAESExecutive Officer and Director
176902
0.0878%
$413,950.6840
+52.37%
NACHTSHEIM JAMI Kdirector
108362
0.0538%
$253,567.0820
+24.68%
Swisher Daniel N JRdirector
107045
0.0531%
$250,485.3035
+12.22%
Gregory Dean A.director
86725
0.043%
$202,936.5020
+24.33%
SCHULZE GAILdirector
83420
0.0414%
$195,202.8014
<0.0001%
Lucena Anndirector
72284
0.0359%
$169,144.5610
+5.56%
DAWSON WILLIAM JChief Financial Officer
53195
0.0264%
$124,476.3020
+50.47%
Shan Huadirector
32386
0.0161%
$75,783.2410
<0.0001%
MOORE TIMOTHY L.director
7911
0.0039%
$18,511.7420
+33.47%
*Gray background shows insiders who have made transactions during last year

CERS Institutional Investors: Active Positions

Increased Positions84+51.85%14M+9.95%
Decreased Positions69-42.59%9M-6.68%
New Positions24New7MNew
Sold Out Positions18Sold Out943,389Sold Out
Total Postitions177+9.26%146M+3.27%

CERS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$41,331.0010.93%20.98M+250,537+1.21%2025-09-30
Ark Investment Management Llc$37,135.009.82%18.85M-357,416-1.86%2025-09-30
Vanguard Group Inc$21,244.005.62%10.78M+62,663+0.58%2025-09-30
Baker Bros. Advisors Lp$19,716.005.21%10.01M-3M-22.32%2025-09-30
Sumitomo Mitsui Trust Group, Inc.$11,200.002.96%5.69M-384,660-6.34%2025-09-30
Amova Asset Management Americas, Inc.$11,200.002.96%5.69M-376,952-6.22%2025-09-30
Wasatch Advisors Lp$10,912.002.89%5.54M-3M-35.09%2025-09-30
Geode Capital Management, Llc$8,909.002.36%4.52M+173,476+3.99%2025-09-30
Silvercrest Asset Management Group Llc$8,124.002.15%4.12M+637,575+18.29%2025-09-30
Senvest Management, Llc$7,812.002.07%3.97M-40,319-1.01%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.